Joshua K Sabari, MD

ADVOCATEMA KOL

Associate Professor of Medicine · Thoracic Medical Oncology · NYU Langone Health

New York, NY · NPI 1457633589 · ACE owner: Sarah Chen

SONAR-1 co-investigatorSONAR-3 site PIASCO 2026 oral presenterBrain mets specialty87 publications · h-index 22

Conviction

/ 100

Doxsona-enriched bio

Profile

Dr. Joshua Sabari is a thoracic medical oncologist and clinical researcher at NYU Langone Health's Perlmutter Cancer Center, specializing in non-small cell lung cancer with a particular focus on targeted therapies for KRAS-, EGFR-, and ALK-driven disease. He is widely recognized for his contributions to clinical trial design and execution in molecularly-defined NSCLC subsets, with prominent involvement in trials evaluating next-generation kinase inhibitors. Dr. Sabari serves as a co-investigator on the SONAR-1 trial and presented the SONAR-1 brain metastasis subgroup analysis at ASCO 2026.

Profile refreshed 3 days ago · Doxsona enrichment sources: NCBI PubMed, NYU Langone faculty page, conference programs (ASCO, ESMO, WCLC), LinkedIn (public), Twitter/X (@JoshuaSabariMD), media mentions.

Recent SafeScribe captures

Post-ASCO debrief · 2026-06-04
Sarah Chen MSL · NYU Langone in-person
Strong endorsement of brain mets data positioning. Asked about combination strategies (Sonarex + checkpoint, Sonarex + SBRT). Raised concern about lack of OS data — wants to see SONAR-3 interim 2027.
combination strategyOS dataCNS sequencingPOSITIVE
Pre-ASCO planning · 2026-05-12
Sarah Chen MSL · virtual
Reviewed brain mets abstract content. Provided slide edits. Discussed CNS sequencing question — when to start Sonarex vs SRS in newly diagnosed brain mets.

Scientific affinity

KRAS G12C inhibitors94

CNS metastases in NSCLC91

EGFR-mutant NSCLC78

Targeted therapy resistance72

Liquid biopsy / ctDNA58

Combination therapy strategies55

Key metrics

Publications87
First/senior author31
h-index22
MSL touches (Sondrex)18
Ad-boards attended4
Last touch2026-06-04
ACE engagement score9.2 / 10

Upcoming planned

Wed, June 17 · 2:00pm
Post-ASCO debrief follow-up · NYU Langone
Sat, August 8 · TBD
WCLC 2026 Vienna · booth meeting + abstract review
Q3 ad-board (medical)
Sondrex Medical Affairs · invitation accepted

Peer network

Strong ties (co-author / co-investigator)

Julia K Rotow · Dana-Farber
Nasser H Hanna · Indiana U
Christine Bestvina · U Chicago

Weak ties

Heather A Wakelee · Stanford
Joshua Reuss · MedStar Georgetown